ABSTRACT
INTRODUCTION
Inflammation can be described as "the succe ssion of changes which occurs in a living tissue and its reaction to injury of the living micro circulation and related tissues" that aims to perform the dual function of limiting damage and promoting tissue repair 1 and are required for immune surveillance, optimal repair, and regeneration after injury. 2 The cellular inflammatory process is a complex interplay between cells of the blood, blood vessels and cells of the injured tissue that involves a synchronized response of cells to an initial stimulus 3 of mechanical, chemical or immunological stress, infection or injuries. The highly regulated sequence of events in an inflammatory response start with an initial production of proinflammatory mediators like kinins, prostaglandins and histamines that recruit professional inflam matory cell to the site of injury to clear the offending trigger 4 and is followed by an antiinflamma tory phase, in which resident tissue cells may acquire the potential for protecting themselves from further activation and injury. The inflammatory process protects our body from diseases by releasing cells and mediators that combat foreign substances and prevent infection. 5 However when inflammations and inflammatory responses run unimpeded, it may prove to be a gateway for a number of diseases like arthritis, atherosclerosis, insulin resistance and cancer. Inflammation is normally treated using steroids and nonsteroidal antiinflammatory drugs (NSAIDs). Although the therapeutic potential of these modern drugs are undisputable, the side effects they produce remains a major concern. Longterm administration of corticosteroids can cause hyperglycemia, insulin resistance, diabetes mellitus, osteoporosis and anxiety 6 Patients who take NSAIDs have been found to have a 4 to 7 fold increased risk of developing gastric injuries 7 that can range from nausea and dyspepsia to serious gastrointestinal (GI) complications such as peptic ulcer ations complicated by bleeding or perforation 8 leading to considerable morbidity and mortality. Phytomedicine research has a good chance of contributing new strategies through the development of new and better drugs for an evidence based and rational phytotherapy as it involves a multifaceted approach combining botanical, phytochemical, biological, and molecular techniques. and cancer. 16 Various parts of the plant Vernonia cinerea have been used as antimalarial, astringent, antidiarrhoeal and antiviral agent. 17 Literature evidences reveal that the root decoction and stem of V. cinerea have been used in the treatment of diabetes mellitus and human breast cancer. 18, 19 The bark juice of V. arborea is used for treating worms and chewed on the first signs of sprue in southern Sumatra. 20 The plant also has a very good antifungal activity due to the presence of a sesquiterpene Zaluzanin D. 21 Leaf juice is used to treat worms; decoction of bark in fever, leaf extract is also used for treating septic wounds, jaundice fever, wound healing and rheu matic pains.
Given the impressive medicinal potential of the genera and the plant, the present study is an attempt to evaluate the antiinflammatory potential of V. arborea against formalin induced inflammation.
MATERIALS AND METHODS

Plant material
Fresh leaves of V. arborea Buch.Ham. were collected from Kolli Hills, Eastern Ghats, Tamilnadu, India. The botanical identity of the plant was confirmed and authen ticated by Prof. Dr. P. Jayaraman, Director, Institute of Herbal Botany, Plant Anatomy Research Centre, Tambaram, Chennai, Tamilnadu, India and a voucher specimen was deposited (Voucher No. PARC/2012/1239).
Preparation of plant extract
The plant material (Leaf) was shade dried and coarsely powdered. About 500 g of plant material was soaked in ethanol for 48 h. After 48 h of soaking the solvent was distilled off under reduced pressure and dried in vacuum condition.
Experimental animals
Healthy adult Swiss albino male rats, two to three months old and weighing 150220 g were obtained from Tamilnadu Veterinary and Animal Sciences University, Chennai, Tamilnadu. Animals were housed in standard polypropylene cages and were maintained under standard condition of 12:12 hrs. light/dark cycle and at an ambient temperature at 23 ± 2°C, with 65 ± 5% humidity. Animals were fed with standard rat chow pellet obtained from Sai Durga foods and feeds, Bangalore, India and water ad libitum. All the studies were conducted according to the ethical guidelines of CPCSEA after obtaining necessary clearance from Institutional Animal Ethical Committee (Approval No: 790/03/ac/CPCSEA).
Experimental design
Inflammation in experimental models was induced by formalin (0.1 ml/kg bw.) method. Rats were divided into 6 groups and treated accordingly. Rats in Group 3, 4 and 5 were pretreated with ethanolic leaf extract of V.arborea at increasing doses of 100, 200 and 300 mg/kg bw. once daily at 24 hours' time interval. The pretreatment was done to study the protective effect of the ethanolic leaf extract of V. arborea against formalin induced inflammation. Group 1 : Normal male albino wistar rats. Group 2 : Received subplantar injection of 0.1 ml/kg bw. of formalin. 
Measurement of paw edema
The increase in paw edema was measured by Vernier caliper method. 22 The paw thickness was measured before and 6 days after induction of inflammation by using Vernier caliper. The difference in paw thickness after and before induction of inflammation was calculated and presented as mean increase in paw thickness (mm). Where X= mean increase in paw volume, thickness or weight of treated rats Y= mean increase in paw volume, thickness or weight of control rats.
Assay of Antioxidant profile
Determination of Reduced glutathione 23 To 1 ml of homogenate/blood, precipitated 1 ml of TCA and the precipitate was removed by centrifugation. To 5 ml of the supernatant, added 2 ml of DTNB and the total volume was made up to 3 ml with phosphate buffer. The absorbance was read spectrophotometrically at 412 nm.
Assay of glutathione peroxidase 24 The reaction mixture consisted of 0.2 ml each of EDTA, sodium azide, H 2 O 2 , 0.4 ml phosphate buffer and 0.1 ml tissue homogenate. The mixture was incubated at 37ºC at different time intervals. The reaction was arrested by addition of 0.5 ml of TCA and the tubes were centri fuged at 2000 rpm. To 0.5 ml of supernatant, 4 ml of disodium hydrogen phosphate and 0.5 ml of DTNB were added and the colour developed was read spectro photometrically at 420 nm immediately.
Assay of Super oxide dismutase 25
To the tubes containing 0.75 ml ethanol and 0.15 ml chloroform (chilled in ice), 0.1 ml of tissue homogenate was added and centrifuged. To 0.5 ml of supernatant, added 0.5 ml EDTA solution and 1 ml of buffer. The reaction was initiated by the addition of 0.5 ml of epi nephrine and the increase in absorbance was measured spectrophotometrically at 480 nm.
Estimation of Lipid peroxides 26
To 4 ml of 0.85N H 2 SO 4 , 0.1 ml of homogenated tissue was added and mixed gently followed by 0.5 ml of phosphotungstic acid and stirred well. The contents were centrifuged for 10 min. The supernatant was discarded and the sediment mixed with 2.0 ml of N/12 H 2 SO 4 and 0.3 ml of 10% phosphotungstic acid. The mixture was centrifuged for 10 min. The sediment was suspended in 4.0 ml of distilled water and 1 ml of TBA reagent. The tubes were kept in a boiling water bath for 1 hr. After cooling 5 ml of butanol was added to each tube and the colour extracted in the butanol phase was read spectrophotometrically at 532 nm.
Determination of Hemoglobin 27
A series of test tubes were taken and 0.02ml of blood was added to all the test tubes. Then 5ml of Drabkin's reagent was added to all the tubes and the test tubes were allowed to stand for 4 min. The blank was also treated similarly and read colorimetrically at 540 nm.
Enumeration of Red blood cells 28
The anticoagulated blood was sucked into the pipette up to the mark 0.5. It was diluted with RBC diluting fluid by sucking up to 11 th mark. The pipette was shaken for a minute and wiped away the excess of blood using blotting paper. Now placed a drop of blood at the edge of the cover slip which covers the counting chamber. The cells were counted under microscope on the 16 squares in 5 different parts of the fluid. 29 A peripheral blood smear was made from a drop of blood on a microscope slide, which allowed the cells to be examined microscopically. Blood films were made by placing a drop of blood on one end of a slide, and using a spreader slide to disperse the blood over the slide's length. The slide was left to air dry, after which the blood was fixed to the slide by immersing it briefly in methanol. The fixative is essential for good staining and presentation of cellular detail. After fixation, the slide was stained using the MayGrunwaldGiemsa method to distinguish the cells from each other: the basophilic structures (which took up basic dyes) were colored in blue; theacidophilic or eosinophilic structures (which took up acid dyes) were colored in red whereas neutrophilic structures took up both dyes and were colored brownish purple which were observed micro scopically.
Enumeration of Neutrophils, Eosinophils, Lymphocytes and Basophils by differential counting
Enumeration of White blood cells 28 The anticoagulated blood was sucked into the pipette up to the mark 0.5. It was diluted with WBC diluting fluid by sucking up to 11 th mark. The pipette was shaken for minutes and wiped away the excess of blood using blotting paper. Now placed a drop of blood at the edge of the cover slip which covers the counting chamber. The cells were then counted under microscope on the 4 corner squares.
Assay of marker enzymes
Estimation of Glutamate oxaloacetate transaminase (GOT) 30 The assay mixture containing 1ml of substrate and 0.2 ml of serum was incubated for 1 hr. at 37ºC. To the control tubes, serum was added after arresting the reaction by adding of 1 ml of DNPH. The tubes were kept at room temperature for 30 min. Added 0.5 ml of NaOH and the colour developed was read at 540 nm. 30 The assay mixture containing 1ml of substrate and 0.2 ml of serum was incubated for 1 hr. at 37ºC. Added 1 ml of DNPH and kept at room temperature for 20 min. Serum was added to the control tubes after the reaction was arrested by the addition of 1 ml of DNPH. Added 5 ml of NaOH and the colour developed was read at 540 nm. 30 The reaction mixture containing 1.5 ml carbonate buffer, 1 ml di sodium phenyl phosphate, 0.1 ml magnesium chloride and 0.1 ml of serum was incubated at 37ºC for 15 min. The reaction was arrested by the addition of Folin's phenol reagent. Control tubes were also treated similarly but serum was added after the reaction was arrested with Folin's phenol reagent. Added 1ml of sodium carbonate. The colour developed was read after 10 min at 640 nm.
Estimation of Glutamate pyruvate transaminase (GPT)
Estimation of Serum alkaline phosphatase (ALP)
Estimation of Creatine kinase 31
The incubation mixture containing 1.0 ml of double distilled water, 0.1 ml of serum, 0.1 ml of ATP solution, 0.1 ml of magnesium -cysteine reagent and 0.1 ml of creatine was incubated at 37˚C for 20 min. The tubes were centrifuged and the supernatant was used for the estimation of phosphorous. Statistical Analysis: All the results were expressed as mean ± Standard Error of Mean (S.E.M). The data were statistically analyzed by one-way analysis of variance (ANOVA). P values <0.05 were considered as significant.
RESULTS
Effect of ethanolic leaf extract of V. arborea on paw thickness
Subcutaneous injection of diluted formalin into the hind paw elicited a biphasic pattern of painrelated behav iors, an early shortlasting neurogenic phase followed by a second and more sustained inflammatory phase when compared with normal control groups. However, pretreatment with ethanolic leaf extract of V.arborea (ELEVA) showed a significant inhibition (p<0.05) in the late phase of formalin induced pain in a dose depen dent manner which was well comparable with the standard drug indomethacin (Table 1 and Figure 1 ).
Effect of ethanolic leaf extract of V. arborea on the antioxidant status of the experimental models
Formalin induced experimental animals showed a signi ficant decrease (p<0.05) in the levels of antioxidant enzymesand increase in the levels of lipid peroxide when compared with normal control groups indicating tissue damage. Pretreatment with ELEVA resulted in a considerable increase in the enzymatic antioxidant values and decrease in the lipid peroxide levels when compared with the standard drug treated groups which are an indication of the antioxidant property of ELEVA (Table 2, 
Effect of ethanolic leaf extract of V.arborea on Hb, RBC and total WBC levels
Decreased levels of hemoglobin and red blood cells were observed in formalin induced experimental rats when compared with normal control groups, which however on pretreatment with ELEVA in a dose depen dent manner showed good progress which was well comparable with the standard drug treated rats (Table 4 ; Figure 4a , 4b and 4c). Similar results were observed in white blood cell levels.
Effect of ethanolic leaf extract of V.arborea on neutrophils, lymphocytes, eosinophils and basophil levels
A significant increase (p<0.05) in the levels of neu trophils, lymphocytes, eosinophils and basophils were observed in formalin induced experimental animals when compared with normal control groups. However there was a reduction in the population of neutrophils, eosinophils, lymphocytes and basophils in experimental rats pretreated with ELEVA which was well comparable with the standard drug treated groups (Table 5 ; Figure 5a , 5b, 5c and 5d).
Effect of ethanolic leaf extract of V.arborea on serum marker enzyme levels
Increased levels of SGOT, SGPT and ALP were observed in formalin induced animals when compared with normal control groups which subsequently showed a significant decrease (p<0.05) on dose dependent pretreatment with ELEVA which was well comparable with the standard drug treated groups indicating inhi bition of inflammation. Creatine kinase, was found to be increased in formalin induced groups but was subse quently decreased on pretreatment with ELEVA at dose levels of 100, 200, 300 mg/ kg bw. whose effect was on par with the standard drug treated groups (Table 6 ; Figure 6a , 6b, 6c and 6d).
DISCUSSION
Formalininduced experimental models produce a distinct biphasic nociception in the paw, a first phase (lasting the first 5 min) corresponding to acute neurogenic pain, and a second phase (lasting from 15 to 30 min) corresponding to inflammatory pain responses. 32 In the present study, notable edema and inflammation was observed in the experimental animals. Edema formation in the paw is the result of a synergism between various inflammatory mediators that increased vascular perme ability and blood flow. 33 However, pretreatment with ELEVA extracts showed a significant inhibition in the late phase of formalin induced pain in a dose dependent manner which was well comparable with the standard drug indomethacin and also corroborates with the find ings of Young et al. (2005) . 34 Recently, it has been shown that faulty cellular antioxidant systems cause organisms to develop a series of inflam matory and cancer diseases. 35 The present study also demonstrated a cumulative decrease in the levels of anti oxidant enzymes and considerable increase in the levels of lipid peroxide which is well indicative of tissue damage on induction of formalin in experimental animals. However pretreatment with ELEVA extracts resumed the levels of antioxidants to normalcy accompanied with a notable decrease in the lipid peroxide levels. The results showed a significant increase in the enzymatic antioxidant values at a maximal dose of 300 mg/kg bw. which was on par with the standard drug indomethacin. Cytokines produced by neutrophils are good indicators of progressive inflammation as neutrophils are important sources of free radicals at the site of inflammation. 36 A notable increase in the population of neutrophils in the present study was suggestive of propagation of inflam mation which however was well reduced and reverted close to normalcy in groups pretreated with ELEVA with increasing concentrations. Eosinophils are granu lated molecules that release lipid derived mediators which stimulate responses in tissues which is indicative of inflammation. The present investigation showed an elevated level in their count indicative of the release of cytokines and interleukins in formalin induced experi mental animals accounting to inflammation. However the pretreated groups showed a good reduction in the population of eosinophils that indicate restoration of normal tissues. Lymphocyte is the predominant cell in chronic inflammation. Elevated levels of lymphocytes were observed in formalin induced experimental rats indicative of tissue damage which was reversed in pretreated groups. Basophils appear increased in many specific kinds of inflammatory reactions, particularly those that cause allergic symptoms 37 and were found to be in high numbers in the formalin induced groups in the present study. However the pretreated groups showed a good reduction in the population of basophils. Anemia is a normal pathological condition notable in inflammation due to deprived oxygen supply to the damaged tissue. Hemoglobin and RBC play a major role in the oxygen transport whose levels were clearly observed in decreased amounts in the formalin induced experimental animals. Such a condition was also reported by Swingle & Shideman (1972) . 38 However, pretreatment with the ELEVA at increasing dose levels brought back these levels to near normalcy which was on par with the standard drug treated groups. Total WBC plays a major role in body's defense mecha nism and may increase during inflammation due to the release of interleukins. 39 In the present study, the level of WBC was found to be higher in formalin induced experimental animals. Pretreatment with EEVA at the dose levels of 100, 200, 300 mg/kg bw. Significantly reduced the WBC count indicating substantial recovery from the inflammatory process.
There is increasing evidence that lysosomal enzymes like SGOT, SGPT and ALP play an important role in the development of acute and chronic inflammation. 40 In the present study, pretreatment with ELEVA at dose levels of 100, 200, 300 mg/ kg bw. decreased the levels of SGOT, SGPT, and ALP that were previously found to be increased in formalin induced experimental animals. Biochemical enzymes such as Creatine kinase are well established biomarkers that are often released upon cellular degeneration such as necrosis and inflammation.
41
Increase in Creatine kinase concentrations are related to the irreversible injury which was also well observed in the present investigation in experimental animals after formalin induction which on pretreatment with ELEVA in a dose dependent manner showed reversion to normalcy.
CONCLUSION
The results obtained from the present study show promising signs about the antiinflammatory potential of the ethanol leaf extract of V. arborea against formalin induced inflammation. The extract exhibits appreciable antiinflammatory activity at a dosage of 300 mg/kg b.w. The next course of study would be to identify and isolate the antiinflammatory active principles of this plant, evaluate their antiinflammatory effect and to decipher the mechanism of action involved.
